ad
This Article
Right arrow Images Only
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Articles in Pediatrics
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

The first 300 words of the full text of this section appear below.

Section 3. Summaries of Infectious Diseases

Hepatitis B

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures
Special Considerations

Top
 Next
CLINICAL MANIFESTATIONS: People with hepatitis B virus (HBV) infection may present with a variety of signs and symptoms, including subacute illness with nonspecific symptoms (eg, anorexia, nausea, or malaise), clinical hepatitis with jaundice, or fulminant fatal hepatitis. Asymptomatic seroconversion is common, and the likelihood of developing symptoms of hepatitis is age dependent. Anicteric or asymptomatic infection is most common in young children. Extrahepatic manifestations, such as arthralgias, arthritis, macular rashes, thrombocytopenia, or papular acrodermatitis (Gianotti-Crosti syndrome), can occur early in the course of the illness and may precede jaundice. Acute HBV infection cannot be distinguished from other forms of acute viral hepatitis on the basis of clinical signs and symptoms or nonspecific laboratory findings. Chronic HBV infection is defined as presence of hepatitis B surface antigen (HBsAg) in serum for at least 6 months or by the presence of HBsAg in a person who tests negative for antibody of the immunoglobulin (Ig) M subclass to hepatitis B core antigen (anti-HBc).

Age at the time of acute infection is the primary determinant of the risk of progressing to chronic infection. More than 90% of infants infected perinatally will develop chronic HBV infection. Between 25% and 50% of children infected between 1 and 5 years of age become chronically infected, whereas only 2% to 6% of acutely infected older children and adults develop chronic HBV infections. Patients who develop acute HBV infection while immunosuppressed or with an underlying chronic illness have an increased risk of developing chronic infection. Up to 25% of infants and older children who acquire chronic HBV infection eventually develop HBV-related hepatocellular carcinoma or cirrhosis.

The clinical outcome of untreated chronic HBV infection varies according . . . [Go to Full Text]


Related text in Red Book:

Summary of Major Changes in the 2006 Red Book

Red Book 2006: xxix. [Extract] [Full Version]  

Lapsed Immunizations

Red Book 2006: 35. [Extract] [Full Version]  

Reporting of Adverse Events

Red Book 2006: 41-50. [Extract] [Full Version]  

Vaccine Administration

Red Book 2006: 18-22. [Extract] [Full Version]  

Minimum Ages and Minimum Intervals Between Vaccine Doses

Red Book 2006: 25-33. [Extract] [Full Version]  

Interchangeability of Vaccine Products

Red Book 2006: 33. [Extract] [Full Version]  

Simultaneous Administration of Multiple Vaccines

Red Book 2006: 34. [Extract] [Full Version]  

Preterm and Low Birth Weight Infants

Red Book 2006: 67-69. [Extract] [Full Version]  

Refugees and Immigrants

Red Book 2006: 96-98. [Extract] [Full Version]  

International Travel

Red Book 2006: 98-103. [Extract] [Full Version]  

Active Immunization After Exposure to Disease

Red Book 2006: 86-87. [Extract] [Full Version]  

Children in Residential Institutions

Red Book 2006: 90-92. [Extract] [Full Version]  

Viral Hepatitis

Red Book 2006: 183-185. [Extract] [Full Version]  

Injuries From Discarded Needles in the Community

Red Book 2006: 188-191. [Extract] [Full Version]  

Bite Wounds

Red Book 2006: 191-195. [Extract] [Full Version]  

Blood Safety: Reducing the Risk of Transfusion-Transmitted Infections

Red Book 2006: 106-112. [Extract] [Full Version]  

Transfusion-Transmitted Agents: Known Threats and Potential Pathogens

Red Book 2006: 113-121. [Extract] [Full Version]  

Human Milk

Red Book 2006: 123-124. [Extract] [Full Version]  

Transmission of Infectious Agents via Human Milk

Red Book 2006: 124-128. [Extract] [Full Version]  

Children in Out-of-Home Child Care

Red Book 2006: 130. [Extract] [Full Version]  

Infectious Diseases—Epidemiology and Control

Red Book 2006: 135-142. [Extract] [Full Version]  

Infection Control and Prevention in Ambulatory Settings

Red Book 2006: 164-166. [Extract] [Full Version]  

Hepatitis and Youth in Corrections Settings

Red Book 2006: 177-178. [Extract] [Full Version]  

Hepatitis B

Red Book 2006: 179-181. [Extract] [Full Version]  

Haemophilus influenzae Infections

Red Book 2006: 310-318. [Extract] [Full Version]  

Hepatitis A

Red Book 2006: 326-335. [Extract] [Full Version]  

Human Immunodeficiency Virus Infection

Red Book 2006: 378-401. [Extract] [Full Version]  

Pertussis (Whooping Cough)

Red Book 2006: 498-520. [Extract] [Full Version]  



This topic has been referenced by these articles:

  • Lieu, T. A., Davis, R. L., Capra, A. M., Mell, L. K., Quesenberry, C. P., Martin, K. E., Zavitkovsky, A., Black, S. B., Shinefield, H. R., Thompson, R. S., Rodewald, L. E. (2001). Variation in Clinician Recommendations for Multiple Injections During Adoption of Inactivated Polio Vaccine. Pediatrics 107: e49-e49 [Abstract] [Full Version]  
  • Strine, T. W., Barker, L. E., Mokdad, A. H., Luman, E. T., Sutter, R. W., Chu, S. Y. (2002). Vaccination Coverage of Foreign-Born Children 19 to 35 Months of Age: Findings From the National Immunization Survey, 1999-2000. Pediatrics 110: e15-15 [Abstract] [Full Version]  
  • Freed, G. L., Cowan, A. E., Clark, S. J., Santoli, J., Bradley, J. (2006). Use of a New Combined Vaccine in Pediatric Practices. Pediatrics 118: e251-e257 [Abstract] [Full Version]  
  • Gust, D. A., Strine, T. W., Maurice, E., Smith, P., Yusuf, H., Wilkinson, M., Battaglia, M., Wright, R., Schwartz, B. (2004). Underimmunization Among Children: Effects of Vaccine Safety Concerns on Immunization Status. Pediatrics 114: e16-e22 [Abstract] [Full Version]  
  • Luman, E. T., McCauley, M. M., Stokley, S., Chu, S. Y., Pickering, L. K. (2002). Timeliness of Childhood Immunizations. Pediatrics 110: 935-939 [Abstract] [Full Version]  
  • Glauber, J. H. (2003). The Immunization Delivery Effectiveness Assessment Score: A Better Immunization Measure?. Pediatrics 112: e39-45 [Abstract] [Full Version]  
  • Middleman, A. B., Kozinetz, C. A., Robertson, L. M., DuRant, R. H., Emans, S. J. (2001). The Effect of Late Doses on the Achievement of Seroprotection and Antibody Titer Levels With Hepatitis B Immunization Among Adolescents. Pediatrics 107: 1065-1069 [Abstract] [Full Version]  
  • McPhee, S. J., Nguyen, T., Euler, G. L., Mock, J., Wong, C., Lam, T., Nguyen, W., Nguyen, S., Huynh Ha, M. Q., Do, S. T., Buu, C. (2003). Successful Promotion of Hepatitis B Vaccinations Among Vietnamese-American Children Ages 3 to 18: Results of a Controlled Trial. Pediatrics 111: 1278-1288 [Abstract] [Full Version]  
  • Kirmani, K. I., Lofthus, G., Pichichero, M. E., Voloshen, T., D'Angio, C. T. (2002). Seven-Year Follow-up of Vaccine Response in Extremely Premature Infants. Pediatrics 109: 498-504 [Abstract] [Full Version]  
  • Duval, B., Deceuninck, G., Middleman, A. B. (2002). Seroprotection Rates After Late Doses of Hepatitis B Vaccine. Pediatrics 109: 350-351 [Full Version]  
  • Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S. (2003). Risk of Anaphylaxis After Vaccination of Children and Adolescents. Pediatrics 112: 815-820 [Abstract] [Full Version]  
  • Omenaca, F., Garcia-Sicilia, J., Garcia-Corbeira, P., Boceta, R., Romero, A., Lopez, G., Dal-Re, R. (2005). Response of Preterm Newborns to Immunization With a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B Virus-Inactivated Polio and Haemophilus influenzae Type b Vaccine: First Experiences and Solutions to a Serious and Sensitive Issue. Pediatrics 116: 1292-1298 [Abstract] [Full Version]  
  • Committee on Infectious Diseases, (2004). Recommended Childhood and Adolescent Immunization Schedule--United States, January-June 2004. Pediatrics 113: 142-143 [Full Version]  
  • Committee on Infectious Diseases, (2003). Recommended Childhood and Adolescent Immunization Schedule--United States, 2003. Pediatrics 111: 212-216 [Full Version]  
  • Committee on Infectious Diseases, (2002). Recommended Childhood Immunization Schedule--United States, 2002. Pediatrics 109: 162-162 [Full Version]  
  • Shete, P. B., Daum, R. S. (2002). Real Versus Theoretical: Assessing the Risks and Benefits of Postponing the Hepatitis B Vaccine Birth Dose. Pediatrics 109: 701-703 [Full Version]  
  • Moss, M. H. (2004). RISK OF ANAPHYLAXIS AFTER VACCINATION OF CHILDREN AND ADOLESCENTS. Pediatrics 114: 524-524 [Full Version]  
  • Shih, H.-H., Lin, T.-M., Chuang, J.-H., Eng, H.-L., Juo, S.-H. H., Huang, F.-C., Chen, C.-L., Chen, H.-L. (2005). Promoter Polymorphism of the CD14 Endotoxin Receptor Gene Is Associated With Biliary Atresia and Idiopathic Neonatal Cholestasis. Pediatrics 116: 437-441 [Abstract] [Full Version]  
  • Lunn, E. R., Hoggarth, B. J., Cook, W. J. (2000). Prolonged Hepatitis B Surface Antigenemia After Vaccination. Pediatrics 105: 81e-81 [Abstract] [Full Version]  
  • Schaffer, S. J., Szilagyi, P. G., Shone, L. P., Ambrose, S. J., Dunn, M. K., Barth, R. D., Edwards, K., Weinberg, G. A., Balter, S., Schwartz, B. (2002). Physician Perspectives Regarding Pneumococcal Conjugate Vaccine. Pediatrics 110: e68-68 [Abstract] [Full Version]  
  • Belloni, C., Avanzini, M. A., De Silvestri, A., Martinetti, M., Pasi, A., Coslovich, E., Autelli, M., Masanti, M. L., Cuccia, M., Tinelli, C., Rondini, G., Lorini, R. (2002). No Evidence of Autoimmunity in 6-Year-Old Children Immunized at Birth With Recombinant Hepatitis B Vaccine. Pediatrics 110: e4-4 [Abstract] [Full Version]  
  • Cabana, M. D., Aiken, K. D., Clark, S. J. (2002). Newborn Hepatitis B Vaccination Policy in Hospital Nurseries. Pediatrics 109: e21-21 [Abstract] [Full Version]  
  • Aach, R. D., Yomtovian, R. A., Hack, M. (2000). Neonatal and Pediatric Posttransfusion Hepatitis C: A Look Back and a Look Forward. Pediatrics 105: 836-842 [Full Version]  
  • Yim, R., Wald, E. R. (2005). Misinterpretation of Liver-Function Tests and West Nile Virus Infection in Children: In Reply. Pediatrics 115: 1445-1446 [Full Version]  
  • Santoli, J. M., Huet, N. J., Smith, P. J., Barker, L. E., Rodewald, L. E., Inkelas, M., Olson, L. M., Halfon, N. (2004). Insurance Status and Vaccination Coverage Among US Preschool Children. Pediatrics 113: 1959-1964 [Abstract] [Full Version]  
  • Biroscak, B. J., Fiore, A. E., Fasano, N., Fineis, P., Collins, M. P., Stoltman, G. (2003). Impact of the Thimerosal Controversy on Hepatitis B Vaccine Coverage of Infants Born to Women of Unknown Hepatitis B Surface Antigen Status in Michigan. Pediatrics 111: e645-649 [Abstract] [Full Version]  
  • Hurie, M. B., Saari, T. N., Davis, J. P. (2001). Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on Thimerosal in Vaccines on Hospital Infant Hepatitis B Vaccination Practices. Pediatrics 107: 755-758 [Abstract] [Full Version]  
  • Taylor, J. A., Darden, P. M., Brooks, D. A., Hendricks, J. W., Baker, A. E., Bocian, A. B., Rohder, K., Wasserman, R. C. (2001). Impact of the Change to Inactivated Poliovirus Vaccine on the Immunization Status of Young Children in the United States: A Study From Pediatric Research in Office Settings and the National Medical Association. Pediatrics 107 : e90-e90 [Abstract] [Full Version]  
  • Berman, S., Armon, C., Todd, J. (2005). Impact of a Decline in Colorado Medicaid Managed Care Enrollment on Access and Quality of Preventive Primary Care Services. Pediatrics 116: 1474-1479 [Abstract] [Full Version]  
  • Saari, T. N., and Committee on Infectious Diseases, (2003). Immunization of Preterm and Low Birth Weight Infants. Pediatrics 112: 193-198 [Abstract] [Full Version]  
  • Miller, L. C., Comfort, K., Kelly, N. (2001). Immunization Status of Internationally Adopted Children. Pediatrics 108: 1050-1051 [Full Version]  
  • DuVernoy, T. S., Braun, M. M., the VAERS Working Group, (2000). Hypotonic-Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Pediatrics 106: 52e-52 [Abstract] [Full Version]  
  • Posfay-Barbe, K. M., Heininger, U., Aebi, C., Desgrandchamps, D., Vaudaux, B., Siegrist, C.-A. (2005). How Do Physicians Immunize Their Own Children? Differences Among Pediatricians and Nonpediatricians. Pediatrics 116: e623-e633 [Abstract] [Full Version]  
  • Gonzalez, I. M., Averhoff, F. M., Massoudi, M. S., Yusuf, H., DeStefano, F., Kramarz, P., Maher, J. E., Mullooly, J. P., Chun, C., Davis, R. L., Black, S. B., Shinefield, H. R. (2002). Hepatitis B Vaccination Among Adolescents in 3 Large Health Maintenance Organizations. Pediatrics 110: 929-934 [Abstract] [Full Version]  
  • Euler, G. L., Wooten, K. G., Baughman, A. L., Williams, W. W. (2003). Hepatitis B Surface Antigen Prevalence Among Pregnant Women in Urban Areas: Implications for Testing, Reporting, and Preventing Perinatal Transmission. Pediatrics 111: 1192-1197 [Abstract] [Full Version]  
  • Jenkins, C. N. H., McPhee, S. J., Wong, C., Nguyen, T., Euler, G. L. (2000). Hepatitis B Immunization Coverage Among Vietnamese-American Children 3 to 18 Years Old. Pediatrics 106: 78e-78 [Abstract] [Full Version]  
  • Miller, L. C., Hendrie, N. W. (2000). Health of Children Adopted From China. Pediatrics 105: 76e-76 [Abstract] [Full Version]  
  • Stein, M. T., Tipnis, N. A., Schultz, P. (2004). Fatigue, Decreased Interest in Play, Motor Delay, and Elevated Liver-Function Tests in a 4-Year-Old Boy. Pediatrics 114: 1437-1441 [Full Version]  
  • Schulte, J. M., Maloney, S., Aronson, J., Gabriel, P. S., Zhou, J., Saiman, L. (2002). Evaluating Acceptability and Completeness of Overseas Immunization Records of Internationally Adopted Children. Pediatrics 109: e22-22 [Abstract] [Full Version]  
  • Coleman, E. (2003). Ethylmercury in Vaccines. Pediatrics 111: 922-923 [Full Version]  
  • Zhou, F., Euler, G. L., McPhee, S. J., Nguyen, T., Lam, T., Wong, C., Mock, J. (2003). Economic Analysis of Promotion of Hepatitis B Vaccinations Among Vietnamese-American Children and Adolescents in Houston and Dallas. Pediatrics 111: 1289-1296 [Abstract] [Full Version]  
  • Shefer, A., Webb, E., Wilmoth, T. (2000). Determination of Up-to-Date Vaccination Status for Preschool-Aged Children: How Accurate Is Manual Assessment Conducted by Paraprofessional Staff?. Pediatrics 106: 493-496 [Abstract] [Full Version]  
  • Smith, P. J., Chu, S. Y., Barker, L. E. (2004). Children Who Have Received No Vaccines: Who Are They and Where Do They Live?. Pediatrics 114: 187-195 [Abstract] [Full Version]  
  • DeStefano, F., Mullooly, J. P., Okoro, C. A., Chen, R. T., Marcy, S. M., Ward, J. I., Vadheim, C. M., Black, S. B., Shinefield, H. R., Davis, R. L., Bohlke, K. (2001). Childhood Vaccinations, Vaccination Timing, and Risk of Type 1 Diabetes Mellitus. Pediatrics 108: e112-112 [Abstract] [Full Version]  
  • Armstrong, G. L., Mast, E. E., Wojczynski, M., Margolis, H. S. (2001). Childhood Hepatitis B Virus Infections in the United States Before Hepatitis B Immunization. Pediatrics 108: 1123-1128 [Abstract] [Full Version]  
  • Berman, S. (2000). Child Health Policymaking. Pediatrics 105: 638-640 [Full Version]  
  • Berman, S. (2005). Challenge of Transforming Our Private and Public Pediatric Health Care Systems to Emphasize Value. Pediatrics 115: 1068-1070 [Full Version]  
  • Joyce, T., Racine, A. (2005). CHIP Shots: Association Between the State Children's Health Insurance Programs and Immunization Rates. Pediatrics 115: e526-e534 [Abstract] [Full Version]  
  • Fleischer, D., Wood, R. A. (2003). CHILDHOOD VACCINATIONS AND RISK OF ASTHMA. Pediatrics 112: 478-479 [Full Version]  
  • Halsey, N. A., Goldman, L. (2001). Balancing Risks and Benefits: Primum non nocere Is Too Simplistic. Pediatrics 108: 466-467 [Full Version]  
  • Cooper, A., Yusuf, H., Rodewald, L., Malik, T., Pollard, R., Pickering, L. (2001). Attitudes, Practices, and Preferences of Pediatricians Regarding Initiation of Hepatitis B Immunization at Birth. Pediatrics 108: e98-98 [Abstract] [Full Version]  
  • Bascom, S., Miller, S., Greenblatt, J. (2005). Assessment of Perinatal Hepatitis B and Rubella Prevention in New Hampshire Delivery Hospitals. Pediatrics 115: e594-e599 [Abstract] [Full Version]  
  • Poland, G. A. (2001). Adolescent Hepatitis B Immunization: Making It Simpler. Pediatrics 107: 771-772 [Full Version]  
  • Aggarwal, M., Rein, J. (2003). Acute Human Immunodeficiency Virus Syndrome in an Adolescent. Pediatrics 112: e323-323 [Abstract] [Full Version]  
  • Cassidy, W. M., Watson, B., Ioli, V. A., Williams, K., Bird, S., West, D. J. (2001). A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic Memory. Pediatrics 107: 626-631 [Abstract] [Full Version]  
  • Meyerhoff, A. S., Greenberg, D. P., Levaux, H. P. (2002). 2-Dose Hepatitis Vaccination Versus 3-Dose Regimen. Pediatrics 109: 1183-1184 [Full Version]